ROTEM platelet

Transkript

ROTEM platelet
ROTEM platelet
®
with ROTEM®delta
ROTEM®platelet supplements the platelet function analysis
for ROTEM®– guided peri-operative bleeding management
Measures platelet function and aggregation in whole blood samples
Single use test reagents for the detection of aggregation disorders
Fast and safe handling through touch-screen instructions
Proven technologies in one ROTEM®system
NEW
ROTEM®platelet
Proven
technologies
in one system
The ROTEM®platelet measures platelet aggregation in whole blood samples
using impedance aggregometry. The new device is run in conjunction with
the ROTEM®delta, and is compatible with all existing ROTEM®delta models
with serial numbers >2000. The ROTEM ®platelet characteristics are:
–
–
–
–
Dedicated single use cuvettes with electrodes
2 channels can be used simultaneously (for one patient sample)
Measurement time is 6min, while allowing for emergency samples
3 different parameters are available:
A6 (amplitude at 6min in Ohm)
MS (maximum slope of the aggregation graph in Ohm/min)
AUC (area under the curve in Ohm*min)
Measurements can be performed on the ROTEM®platelet device while
running measurements on the ROTEM ®delta system simultaneously.
Single Use
Reagents
adp-tem
ROTEM ®platelet detection principle
®
e.g. for the detection of
ADP receptor blockage
(Clopidogrel)
ara-tem ®
trap-tem ®
Data processing
e.g. for the detection e.g. for the detection
of cyclooxygenase
of GP llb/llla receptor
inhibitors (Aspirin ®) antagonists (Abciximab)
Reaction curve
MS (Ohm/min)
A6 (Ohm)
AUC (Ohm*min)
Resistance between
two electrodes is
measured
After adding
aggregation agents
the platelets are
activated
Platelets aggregate
on electrodes and
increase electrical
resistance
www.rotem.de
[email protected]
tem
®
Tem International GmbH
Martin-Kollar-Strasse 13-15
81829 Munich, Germany
T:+49 (0)89 454295-0
F:+49 (0)89 454295-22
© ROTEM®platelet 10/2013 en v002
Contact

Podobné dokumenty

Nestabilní angina pectoris

Nestabilní angina pectoris  riziko nízké: farmakoterapie, zátěžový test a podle jeho výsledku indikace SKG  riziko vysoké: farmakoterapie včetně i.v. GP IIb/IIIa inhibitoru, urgentní katetrizace a intervence podle nálezu: ...

Více